跳至主要内容
临床试验/IRCT20190504043464N1
IRCT20190504043464N1已完成1 期

Investigation of the Immunogenicity and Safety of Lactococcus Lactis Vaccine Containing Codon-Optimized Full-Length E7 and E6 Oncoproteins of HPV-16 in Healthy Women

Iran University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 59 years(—)
性别
Female

入选标准

  • 1- People Voluntarily Participate in the Research.
  • 2- The Informed Consent Form Is Completed and Signed by the Person or Her companion.
  • 3- Women PCR positive test for Papilloma Virus Infection.
  • 4. Women Don't Have other sexually transmitted diseases.
  • Women Don't be Pregnant
  • 6. Women in Pap smear Test Don't Have Abnormal Conditions.

排除标准

  • 1. People Don't Have Cancerous Disease During the Course of Treatment.
  • 2. Failure to Complete a Course of Treatment by Individuals Will Result in Their Exclusion from Study.
  • 3- Getting Pregnant During the Course of Treatment Will Leave Women Out of Study.

研究者

相似试验